Bio-View Ltd (TLV:BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA 28.00
-0.20 (-0.71%)
Apr 2, 2025, 5:24 PM IDT
Bio-View Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -3.15 | 0.38 | 0.59 | 2.18 | 0.88 | Upgrade
|
| Depreciation & Amortization | 1.7 | 1.82 | 1.5 | 1.48 | 1.23 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.01 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.22 | -0.02 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.16 | 0.01 | 0.04 | 0.08 | 0.06 | Upgrade
|
| Other Operating Activities | -0.33 | -0.08 | 0.19 | -0.19 | -0.13 | Upgrade
|
| Change in Accounts Receivable | 2.76 | -2.07 | -0.68 | -1.24 | 1.01 | Upgrade
|
| Change in Inventory | -2.04 | -1.05 | -0.43 | -0.26 | -0.66 | Upgrade
|
| Change in Accounts Payable | -1.93 | 0.89 | 0.36 | 0.11 | -0.15 | Upgrade
|
| Change in Unearned Revenue | -1.17 | 1.22 | 0.17 | 0.62 | -1.12 | Upgrade
|
| Change in Other Net Operating Assets | 0.66 | -0.95 | -0.77 | 0.47 | -0.32 | Upgrade
|
| Operating Cash Flow | -3.11 | 0.15 | 0.97 | 3.25 | 0.8 | Upgrade
|
| Operating Cash Flow Growth | - | -84.19% | -70.19% | 304.86% | -67.87% | Upgrade
|
| Capital Expenditures | -0.04 | -0.27 | -0.46 | -0.66 | -0.3 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | Upgrade
|
| Investment in Securities | -1.52 | -1.41 | - | - | - | Upgrade
|
| Other Investing Activities | 0.01 | 0.01 | -0.11 | -0.1 | -0.01 | Upgrade
|
| Investing Cash Flow | -1.54 | -1.67 | -0.57 | -0.74 | -0.31 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.59 | - | Upgrade
|
| Long-Term Debt Repaid | -1.55 | -1 | -1.36 | -0.86 | -1.03 | Upgrade
|
| Net Debt Issued (Repaid) | -1.55 | -1 | -1.36 | -0.27 | -1.03 | Upgrade
|
| Issuance of Common Stock | - | 0.07 | - | - | 0.1 | Upgrade
|
| Repurchase of Common Stock | -1.4 | -1.74 | -0.26 | - | -0.67 | Upgrade
|
| Financing Cash Flow | -2.95 | -2.68 | -1.61 | -0.27 | -1.6 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.13 | 0.46 | 1.43 | -0.26 | -0.39 | Upgrade
|
| Net Cash Flow | -7.47 | -3.75 | 0.21 | 1.98 | -1.5 | Upgrade
|
| Free Cash Flow | -3.14 | -0.12 | 0.51 | 2.59 | 0.5 | Upgrade
|
| Free Cash Flow Growth | - | - | -80.25% | 419.68% | -78.23% | Upgrade
|
| Free Cash Flow Margin | -12.24% | -0.35% | 1.75% | 8.48% | 1.92% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.00 | 0.00 | 0.02 | 0.00 | Upgrade
|
| Cash Interest Paid | - | 0.2 | 0.24 | 0.23 | 0.05 | Upgrade
|
| Cash Income Tax Paid | - | 0.4 | 0.04 | - | 0.09 | Upgrade
|
| Levered Free Cash Flow | -0.13 | -0.32 | 0.51 | 1.53 | 0.2 | Upgrade
|
| Unlevered Free Cash Flow | -0.13 | -0.12 | 0.66 | 1.68 | 0.23 | Upgrade
|
| Change in Net Working Capital | - | 1.76 | 0.49 | 0.82 | 1.5 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.